MY117328A - Production process for intravenous immune serum globulin and resultant product. - Google Patents
Production process for intravenous immune serum globulin and resultant product.Info
- Publication number
- MY117328A MY117328A MYPI98005848A MYPI9805848A MY117328A MY 117328 A MY117328 A MY 117328A MY PI98005848 A MYPI98005848 A MY PI98005848A MY PI9805848 A MYPI9805848 A MY PI9805848A MY 117328 A MY117328 A MY 117328A
- Authority
- MY
- Malaysia
- Prior art keywords
- production process
- resultant product
- immune serum
- intravenous immune
- serum globulin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99795297A | 1997-12-24 | 1997-12-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
MY117328A true MY117328A (en) | 2004-06-30 |
Family
ID=25544595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI98005848A MY117328A (en) | 1997-12-24 | 1998-12-23 | Production process for intravenous immune serum globulin and resultant product. |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0971727A4 (ru) |
JP (1) | JP2001514672A (ru) |
KR (1) | KR20000075562A (ru) |
CN (1) | CN1214042C (ru) |
AR (1) | AR018260A1 (ru) |
AU (1) | AU747893B2 (ru) |
BR (1) | BR9807598A (ru) |
CA (1) | CA2281938A1 (ru) |
CO (1) | CO4970799A1 (ru) |
IL (1) | IL131471A0 (ru) |
MY (1) | MY117328A (ru) |
RU (1) | RU2198668C2 (ru) |
TW (1) | TW546144B (ru) |
UA (1) | UA64742C2 (ru) |
WO (1) | WO1999033484A1 (ru) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4685238B2 (ja) * | 1998-06-09 | 2011-05-18 | ツエー・エス・エル・ベーリング・アクチエンゲゼルシヤフト | 静脈投与用免疫グロブリン及び他の免疫グロブリン生成物の製造法 |
JP2003501480A (ja) * | 1999-06-15 | 2003-01-14 | アルファ・セラピューティック・コーポレーション | 静注用免疫グロブリンの製造方法および製剤 |
WO2002026258A2 (en) * | 2000-09-28 | 2002-04-04 | Research Corporation Technologies, Inc. | Treatment of immune-mediated diseases by oral administration of plasma fractions |
ES2184594B1 (es) | 2001-01-17 | 2004-01-01 | Probitas Pharma Sa | Procedimiento para la produccion de gammaglobulina g humana inactivada de virus. |
US6893639B2 (en) | 2001-10-19 | 2005-05-17 | Hemacare Corporation | Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates |
CN100522989C (zh) | 2002-09-11 | 2009-08-05 | 中外制药株式会社 | 纯化蛋白质的方法 |
TWI320788B (en) | 2005-05-25 | 2010-02-21 | Hoffmann La Roche | Method for the purification of antibodies |
KR100791502B1 (ko) * | 2006-09-29 | 2008-01-03 | 한스바이오메드 주식회사 | 바이러스 불활화된 무세포 인체 이식재 생산방법 |
CA2742817A1 (en) * | 2008-11-20 | 2010-05-27 | Biogen Idec Ma Inc. | Arginine inactivation of viruses |
IL212911A0 (en) * | 2011-05-16 | 2011-07-31 | Omrix Biopharmaceuticals Ltd | Immunoglobulin reduced in thrombogenic contaminants and preparation thereof |
ES2381828B1 (es) * | 2012-03-20 | 2012-11-16 | Grifols, S.A. | PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO |
CA2941230C (en) | 2014-03-11 | 2020-08-25 | Green Cross Holdings Corporation | Method for purifying immunoglobulin |
CN107880116B (zh) * | 2016-09-30 | 2023-02-03 | 盖立复集团公司 | 用于制备免疫球蛋白的方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2604759C2 (de) * | 1976-02-07 | 1983-06-01 | SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld | Verfahren zur Gewinnung von iv-verträglichen Γglobulinen |
US4820805A (en) * | 1983-07-14 | 1989-04-11 | New York Blood Center, Inc. | Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives |
US4835257A (en) * | 1984-07-07 | 1989-05-30 | Armour Pharma Gmbh | Process for preparing gamma globulin suitable for intravenous administration using peg and a citrate buffer |
FR2582515B1 (fr) * | 1985-05-30 | 1988-11-04 | Merieux Inst | Procede de preparation de gamma-gobulines administrables par voie intraveineuse et gamma-globulines obtenues |
JPH0662436B2 (ja) * | 1986-05-19 | 1994-08-17 | 株式会社ミドリ十字 | 静注用免疫グロブリン製剤の製造方法 |
US4841023A (en) * | 1986-06-25 | 1989-06-20 | New York Blood Center, Inc. | Inactivation of viruses in labile protein-containing compositions using fatty acids |
DE3825429C2 (de) * | 1988-07-27 | 1994-02-10 | Biotest Pharma Gmbh | Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt |
JP2965069B2 (ja) * | 1989-01-13 | 1999-10-18 | 吉富製薬株式会社 | 蛋白質含有組成物の製造方法 |
EP0378208B2 (en) * | 1989-01-13 | 2003-01-15 | Mitsubishi Pharma Corporation | Production method for protein-containing composition |
DE69027187T2 (de) * | 1989-06-15 | 1996-10-31 | Rorer Int Overseas | Verfahren zur inaktivierung von viren in mit viren verunreinigten pharmazeutischen zusammensetzungen |
US5177194A (en) * | 1990-02-01 | 1993-01-05 | Baxter International, Inc. | Process for purifying immune serum globulins |
JP3145696B2 (ja) * | 1990-10-05 | 2001-03-12 | 日本ケミカルリサーチ株式会社 | 分泌型免疫グロブリンa製剤の製造法 |
US5110910A (en) * | 1991-03-25 | 1992-05-05 | Miles Inc. | Virucidal euglobulin precipitation |
DE4431833C1 (de) * | 1994-09-07 | 1995-05-18 | Blutspendedienst Der Drk Lande | Verfahren zur Herstellung eines AHF-Konzentrates |
JP4003235B2 (ja) * | 1994-09-30 | 2007-11-07 | 三菱ウェルファーマ株式会社 | 静注用免疫グロブリン製剤の製造方法 |
-
1998
- 1998-07-12 UA UA99084781A patent/UA64742C2/ru unknown
- 1998-12-07 WO PCT/US1998/025208 patent/WO1999033484A1/en not_active Application Discontinuation
- 1998-12-07 KR KR1019997007622A patent/KR20000075562A/ko not_active Application Discontinuation
- 1998-12-07 JP JP53498599A patent/JP2001514672A/ja not_active Ceased
- 1998-12-07 EP EP98961803A patent/EP0971727A4/en not_active Withdrawn
- 1998-12-07 CN CNB988043769A patent/CN1214042C/zh not_active Expired - Fee Related
- 1998-12-07 AU AU17038/99A patent/AU747893B2/en not_active Ceased
- 1998-12-07 RU RU99120190/14A patent/RU2198668C2/ru not_active IP Right Cessation
- 1998-12-07 IL IL13147198A patent/IL131471A0/xx unknown
- 1998-12-07 CA CA002281938A patent/CA2281938A1/en not_active Abandoned
- 1998-12-07 BR BR9807598-5A patent/BR9807598A/pt not_active Application Discontinuation
- 1998-12-22 AR ARP980106616A patent/AR018260A1/es unknown
- 1998-12-23 TW TW087121571A patent/TW546144B/zh not_active IP Right Cessation
- 1998-12-23 MY MYPI98005848A patent/MY117328A/en unknown
- 1998-12-23 CO CO98076460A patent/CO4970799A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP2001514672A (ja) | 2001-09-11 |
CN1252729A (zh) | 2000-05-10 |
IL131471A0 (en) | 2001-01-28 |
AU747893B2 (en) | 2002-05-30 |
KR20000075562A (ko) | 2000-12-15 |
BR9807598A (pt) | 2000-02-22 |
EP0971727A1 (en) | 2000-01-19 |
CA2281938A1 (en) | 1999-07-08 |
WO1999033484A1 (en) | 1999-07-08 |
UA64742C2 (ru) | 2004-03-15 |
EP0971727A4 (en) | 2005-01-19 |
AU1703899A (en) | 1999-07-19 |
CN1214042C (zh) | 2005-08-10 |
TW546144B (en) | 2003-08-11 |
RU2198668C2 (ru) | 2003-02-20 |
AR018260A1 (es) | 2001-11-14 |
CO4970799A1 (es) | 2000-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY117328A (en) | Production process for intravenous immune serum globulin and resultant product. | |
GR3034177T3 (en) | Immunoglobulin g concentrate for therapeutical use and method for producing same | |
EP0128522A3 (en) | High titer cytomegalovirus immune serum globulin and method of making same | |
FR2651437B1 (ru) | ||
EP0168234A3 (en) | Purification process for hepatitis surface antigen and product thereof | |
PL299346A1 (en) | Method of theating articles of food and theirt byproducts, articles of food and their byproducts obtained thereby and use of adsorptive resins for treating articles of food and their byproducts | |
GB1488774A (en) | Hepatitis b antigen and method of producing it | |
AU2253392A (en) | Therapeutic fragments of von willebrand factor | |
BR0010815A (pt) | Método de preparação de globulina imune duplamente inativada viralmente para administração intravenosa | |
ES8705230A1 (es) | Procedimiento para preparar gamma-globulinas administrables por via intravenosa | |
ZA971998B (en) | Purification method. | |
SG86990A1 (en) | Process for the quantitative purification of glycolipids | |
AU3876793A (en) | Process for the inactivation of viruses in preparations of proteins | |
BR0011648A (pt) | Método de fabricação de imunoglobulina intravenosa e produto resultante | |
FI893389A (fi) | Foerfarande foer framstaellning av fosfater genom smaeltning. | |
AU1516988A (en) | Method of preparing highly purified alpha-1-proteinase inhibitor | |
AU4811290A (en) | A pure factor i protein and a process for producing said protein | |
PT79232A (en) | Process for producing immune interferon and of pharmaceutical compositions containing the same | |
FI951836A0 (fi) | Menetelmä reaktiotuotteiden valmistamiseksi polydiorganosiloksaaneista | |
DE3467973D1 (en) | Process for the stabilization of hematin |